Miller Tabak's Maley: Plan For Post-Election Market Move(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Matt Maley, Equity Strategist at Miller Tabak, with a macro look at the markets and why he expects a big post-election market moveSe...
3 Loka 201611min
Peter Anderson on John Stumpf Congressional Testimony (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Peter Andersen, chief investment officer at Fiduciary Trust Company, discusses Wells Fargo's recent troubles with accounts and John ...
30 Syys 201611min
Mike Virdi & Narinder Chadha on OurBus Transportation (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mike Virdi and Narinder Chadha, Co-Founders of OurBus, a transit technology startup that allows riders to create their own demand-ba...
30 Syys 201611min
Brean's Tchir Says Deutsche Bank Not a Systemic Risk (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Peter Tchir, Head of Macro Strategy at Brean Capital, on global markets, Deutsche Bank, and the BOJ.See omnystudio.com/listener for ...
29 Syys 201611min
Kiip CEO Brian Wong on New Book, 'The Cheat Code' (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Brian Wong, CEO and Co-Founder of mobile advertising network Kiip, discusses his new book, "The Cheat Code."See omnystudio.com/liste...
29 Syys 20168min
Bloomberg's Wilson on Stock of the Day: Stein Mart (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010Guest:\u0010Bloomberg stocks editor David Wilson on his Stock of the Day: Stein Mart (SMRT).See omnystudio.com/listener for priv...
29 Syys 20162min
Again's Kilduff on OPEC Cut: Oil Still Going Below $40 (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: John Kilduff, Founding partner of Again Capital, on the oil markets, and OPEC curtailing output.See omnystudio.com/listener for priv...
29 Syys 201611min
Rx Savings' Rea on Wide Gaps in EpiPen Drug Pricing (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) an...
29 Syys 20168min
